Copy Link Print Information

Naratuximab

(Synonyms: Anti-TSPAN26/CD37 Reference Antibody (naratuximab))
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine.

For research use only. We do not sell to patients.

  • Purity: 99.9%
  • CAS No.: 1622327-39-2
  • Molecular Weight:143.6 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Naratuximab
  • Experimental Validation Results for Naratuximab
  • Experimental Validation Results for Naratuximab
  • Naratuximab Chemical Structure
    Naratuximab Chemical Structure
CAS No.: 1622327-39-2
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Naratuximab

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized hu-CD37-VLP can bind Naratuximab. The EC50 for this effect is 4.061 ng/mL.

  • 1/16

    Flow Cytometry analysis of Raji cells labelling CD37 (red) with Naratuximab (anti-CD37) (HY-P99374). Goat Anti-Human IgG (FITC) (ZF-0308) at a dilution of 1/100 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.

  • Naratuximab Chemical Structure
    1/16
  • Naratuximab
  • Immobilized hu-CD37-VLP can bind Naratuximab. The EC50 for this effect is 4.061 ng/mL.
  • Flow Cytometry analysis of Raji cells labelling CD37 (red) with Naratuximab (anti-CD37) (HY-P99374). Goat Anti-Human IgG (FITC) (ZF-0308) at a dilution of 1/100 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.